BioBlast w/e 15 Dec 23 : vimarsana.com

Korea Biomed reported that LG Chem’s Xelenka®, biosimilar to AbbVie’s Humira® (adalimumab), has been approved by the Korean Ministry of Food and Drug…

Related Keywords

Taiwan , Slovenia , South Korea , Japan , Lendava , Lendava Lendva , Korea , Samsung Biologics , Biomed Nona Biosciences , Nona Biosciences , Genentech Avastin , Seagen Astella Padcev , Celltrion Vegzelma , Genentech Actemra , Abbvie Humira , Amgen , Korea Ministry Of Food , Intas Pharmaceuticals , Samsung , Korean Ministry Of Food , Lotus , Japan National Health Insurance , Pfizer , Approval Alert , Korean Ministry , Drug Safety , New Indication Alert , Plus Padcev , Urothelial Cancer , Astella Padcev , Biologics License Application , Positive Metastatic Breast , Biomedical Reviewreported , Harbour Biomed , Nona Biosciences Inks , Global License Agreement , Trial Demonstrates Equivalence , Corporate Filings , Grants Priority Review , Intravenous Infusion , Drug Price , Sandoz Subsidiary Lek Commences Construction , Add Celltrion , Preferred Formulary , United States , Medical Benefits Manager Ventegra , Celltrion United States , Commercialise Intas , South East , Law , Lawyers , Legal , Aw Firms , Aw Updates , Egal Updates , Egal Developments , Aw Developments , Egal Newsletters , Egal Current Awareness , Deals , Egal Advisers , Egal Advisors , Egal Directory , Australia , Ealthcare Amp Life Sciences ,